SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Santos, M.
Right arrow Articles by Maciel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santos, M.
Right arrow Articles by Maciel, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin

Mónica Santos

UnIGENe-IBMC, Univ. Porto

Maria do Carmo Costa

UnIGENe-IBMC, Univ. Porto

Maria Edite Rio

Serv. Neurol., Hosp. S. João, Porto

Maria José Sá

Serv. Neurol., Hosp. S. João, Porto

Marta Monteiro

Serv. Neurol., Hosp. S. João, Porto

Angela Valença

Serv. Neurol., Hosp. Força Aérea, Lisboa

Alfredo Sá

Serv. Neurol., Hosp. Dist. Sto. André, Leiria

José Dinis

Serv. Neurol., Hosp. Dist. Sta. Luzia, Viana do Castelo

José Figueiredo

Serv. Neurol., Hosp. S. Marcos, Braga

Luís Bigotte de Almeida

Serv. Neurol., Hosp. Garcia de Orta, Almada

António Valongueiro

Serv. Neurol., Hosp. Dist. Sta. Luzia, Viana do Castelo

Isabel Coelho

Serv. Neurol., Hosp. Dist. Sra. Oliveira, Guimarães

Maria Teresa Matamá

UnIGENe-IBMC, Univ. Porto

Jorge Pinto-Basto

UnIGENe-IBMC, Univ. Porto, Inst. Genét. Médica, Jacinto de Magalhães, Porto

Jorge Sequeiros

UnIGENe-IBMC, Univ. Porto, Dept. Est. Pop., ICBAS, Univ. Porto

Patrícia Maciel

UnIGENe-IBMC, Univ. Porto, Dept. Est. Pop., ICBAS, Univ. Porto, Esc. Ciências da Saúde e ICVS, Univ. Minho, Portugal, pmaciel{at}ecsaude.uminho.pt

Multiple sclerosis (MS) is a demyelinating disease that affects about one in 500 young Europeans. In order to test the previously proposed influence of the A PO E and SC A 2 loci on susceptibility to MS, we studied these loci in 243 Portuguese patients and 192 healthy controls and both parents of 92 patients. We did not detect any significant difference when A PO E and SC A 2 allele frequencies of cases and controls were compared, or when we compared cases with different forms of the disease. Disequilibrium of transmission was tested for both loci in the 92 trios, and we did not observe segregation distortion. To test the influence of the A PO E o4 and SC A 2 22 C AGs alleles on severity of disease, we compared age at onset and progression rate between groups with and without those alleles. We did not observe an association of the o4 or the 22 C AG s alleles with rate of progression in our total patient population; allele o4 was associated with increased rate of progression of MS in a subset of patients with less than 10 years of the disease. However, globally in the Portuguese population, the A PO E and SC A2 genes do not seem to be useful in the clinical context as prognostic markers of this disorder.

Key Words: allelic asso ciation • demyelinating disease • genetics • linkage disequilibrium • prognostic markers • spinocerebellar ataxia

Multiple Sclerosis, Vol. 10, No. 2, 153-157 (2004)
DOI: 10.1191/1352458504ms998oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
A. van der Walt, J. Stankovich, M. Bahlo, B. V. Taylor, I.A.F. van der Mei, S. J. Foote, T. J. Kilpatrick, J. P. Rubio, and H. Butzkueven
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
Neurology, September 29, 2009; 73(13): 1018 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
B A Parmenter, D R Denney, S G Lynch, L S Middleton, and L M Harlan
Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms
Multiple Sclerosis, January 1, 2007; 13(1): 25 - 32.
[Abstract] [PDF]


Home page
NeurologyHome page
R. M. Burwick, P. P. Ramsay, J. L. Haines, S. L. Hauser, J. R. Oksenberg, M. A. Pericak-Vance, S. Schmidt, A. Compston, S. Sawcer, R. Cittadella, et al.
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers
Neurology, May 9, 2006; 66(9): 1373 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M J Sedano, P Calmarza, L Perez, and J M Trejo
No association of apolipoprotein E {epsilon}4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis
Multiple Sclerosis, February 1, 2006; 12(1): 13 - 18.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Pinholt, J L Frederiksen, P S Andersen, and M Christiansen
Apo E in multiple sclerosis and optic neuritis: the Apo E-o4 allele is associated with progression of multiple sclerosis
Multiple Sclerosis, October 1, 2005; 11(5): 511 - 515.
[Abstract] [PDF]



Advertisement